2030 Capital, Llc America Net Worth

What's 2030 America's mailing address?

2030's mailing address filed with the SEC is 1301 SHILOH RD., NW, SUITE 1231, , KENNESAW, GA, 30144.

Insiders trading at Co-Diagnostics Inc

Over the last 7 years, insiders at Co-Diagnostics Inc have traded over $2,459,090 worth of Co-Diagnostics Inc stock and bought 8,205 units worth $11,819,010 . The most active insiders traders include Reed L Benson, James B Nelson és Dwight H Egan. On average, Co-Diagnostics Inc executives and independent directors trade stock every 79 days with the average trade being worth of $38,652. The most recent stock trade was executed by Brian Lee Brown on 20 March 2023, trading 3,000 units of CODX stock currently worth $5,700.

What does Co-Diagnostics Inc do?

co-diagnostics, inc. is a molecular diagnostics company that has acquired certain unique, patented diagnostic testing technology. a utah corporation headquartered in sandy, utah, its primary business is to commercialize its unique, patented technology through sales, development and licensing. the technology is embodied in three patent applications and certain trade secrets, which make dna testing for diseases faster, higher in performance, and more cost efficient than traditional technologies of the past. the company has undertaken completely innovative approaches to develop novel molecular technologies using biophysical models and statistical bioinformatics. it has successfully developed and commercialized a series of assays in the infectious disease area to demonstrate the capability of its technology. the technology on which the inventions are based were created by reference to certain mathematical models invented, designed and refined by dr. brent c. satterfield. the inventions are

Co-Diagnostics Inc executives and stock owners

Co-Diagnostics Inc executives and other stock owners filed with the SEC include:

• Dwight H. Egan,
  Chairman, CEO & Pres
• Dwight Egan,
  Chairman of the Board, President, Chief Executive Officer
• Reed Benson,
  Chief Financial Officer, Secretary
• Brent Satterfield,
  Chief Technology Officer
• Richard Serbin,
  Independent Director
• James Nelson,
  Independent Director
• Eugene Durenard,
  Independent Director
• Edward Murphy,
  Independent Director
• Dr. Brent C. Satterfield Ph.D.,
  Co-Founder & Member of Scientific Advisory Board
• Cameron Gundry,
  Head of Commercialization LATAM/EUR
• Dr. Mayuranki Almaula,
  Sr. VP of Overseas Operations & Strategic Alliances
• Andrew Benson,
  Head of Investor Relations
• Dr. Jesse Montgomery,
  Chief Scientific Officer
• Brian L. Brown CPA,
  CFO & Company Sec.
• Brian Lee Brown,
  Chief Financial Officer
• Llc Reagents,,
  
• 2030 Capital, Llc America,
  10% owner
• Ted Murphy,
  
• Richard David Abbott,
  President